Binding mode analysis of chaetomallic acids (A and B) as farnesyltransferase inhibitors

2021 ◽  
Author(s):  
Ns Hari Moorthy ◽  
C Karthikeyn ◽  
E Manivannan
2019 ◽  
Author(s):  
David Wright ◽  
Fouad Husseini ◽  
Shunzhou Wan ◽  
Christophe Meyer ◽  
Herman Van Vlijmen ◽  
...  

<div>Here, we evaluate the performance of our range of ensemble simulation based binding free energy calculation protocols, called ESMACS (enhanced sampling of molecular dynamics with approximation of continuum solvent) for use in fragment based drug design scenarios. ESMACS is designed to generate reproducible binding affinity predictions from the widely used molecular mechanics Poisson-Boltzmann surface area (MMPBSA) approach. We study ligands designed to target two binding pockets in the lactate dehydogenase A target protein, which vary in size, charge and binding mode. When comparing to experimental results, we obtain excellent statistical rankings across this highly diverse set of ligands. In addition, we investigate three approaches to account for entropic contributions not captured by standard MMPBSA calculations: (1) normal mode analysis, (2) weighted solvent accessible surface area (WSAS) and (3) variational entropy. </div>


2017 ◽  
Vol 10 (2) ◽  
pp. 346-366 ◽  
Author(s):  
Santhi Prada Vellanki ◽  
Ramasree Dulapalli ◽  
Bhargavi Kondagari ◽  
Navaneetha Nambigari ◽  
Rajender Vadija ◽  
...  

ChemMedChem ◽  
2010 ◽  
Vol 5 (3) ◽  
pp. 443-454 ◽  
Author(s):  
Torsten Luksch ◽  
Andreas Blum ◽  
Nina Klee ◽  
Wibke E. Diederich ◽  
Christoph A. Sotriffer ◽  
...  

2003 ◽  
Vol 13 (11) ◽  
pp. 1861-1864 ◽  
Author(s):  
K Van Ommeslaeghe ◽  
G Elaut ◽  
V Brecx ◽  
P Papeleu ◽  
K Iterbeke ◽  
...  

2006 ◽  
Vol 15 (2) ◽  
pp. 352-361 ◽  
Author(s):  
Benjamin A. Shoemaker ◽  
Anna R. Panchenko ◽  
Stephen H. Bryant

MedChemComm ◽  
2017 ◽  
Vol 8 (6) ◽  
pp. 1297-1302 ◽  
Author(s):  
Fanxun Zeng ◽  
Tiantian Qi ◽  
Chunyan Li ◽  
Tingfang Li ◽  
Honglin Li ◽  
...  

A series of 4-thiazolidinone derivatives were synthesized and evaluated as novel human dihydroorotate dehydrogenase (hDHODH) inhibitors.


ChemInform ◽  
2003 ◽  
Vol 34 (36) ◽  
Author(s):  
K. Van Ommeslaeghe ◽  
G. Elaut ◽  
V. Brecx ◽  
P. Papeleu ◽  
K. Iterbeke ◽  
...  

Author(s):  
Priyanka Chandra ◽  
Swastika Ganguly ◽  
Rajdeep Dey ◽  
Biswatrish Sarkar

Introduction: In the present study a novel series of twelve 1-(aryl)-2-(1H-imidazol-1-yl)methanones 3(a-l) were synthesized and characterised by physicochemical and spectral analysis,viz. elemental analysis, IR spectroscopy, NMR spectroscopy. The antibacterial property of the compounds were examined, in order to develop new broad spectrum antibiotics. Methods: The compounds 3(a-l) were synthesised by reacting the corresponding 2-(aryl)-1H-imidazoles 2 with substituted benzoyl chlorides. Binding mode analysis of the most active compound was carried out. Predictive ADME studies were carried out for all the compounds. Results and Discussions: Among the synthesized compounds, (2-(3-nitrophenyl) (2,4-dichlorophenyl) -1Himidazol-1-yl)methanone 3i exhibited highest antibacterial activity. Binding mode analysis of the highest active compound was carried out in the active site of glucosamine-6-phosphate synthase (2VF5).


Sign in / Sign up

Export Citation Format

Share Document